mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
AZ-3146 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
Nutlin-3 |
CCLE |
pan-cancer |
AAC |
0.15 |
0.002 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.002 |
mRNA |
OSI-906 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.003 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.003 |
mRNA |
YM-155 |
GDSC1000 |
pan-cancer |
AAC |
-0.096 |
0.003 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.004 |